Bronte Capital Amalthea Fund

Bronte Capital Amalthea Fund Letter: Valeant is not a normal short; Walking dead oil companies

Bronte Capital Amalthea Fund letter to investors for the month ended February 29, 2016.

Bronte Capital Amalthea Fund had a good month in a stressful market. Our performance is usually good in a weakly downward market and it was during February (+1.8%).

The market recovered fairly rapidly in the last week in February (and the first week of March). We usually do poorly during rapid market spikes, however in February the market spike did not hurt us and left us with positive results for the month.

Prior to the spike we benefited from a well-received earnings report from . . .

SORRY!

This content is exclusively for paying members. Access all of our content on including years of timeless investment news and in depth analysis for only a few dollars a month by signing up here while also supporting quality content and journalism, or learn more about our premium content here

If you are subscribed and having an account error please clear cache and then cookies if that does not work email support@valuewalk.com or click chat button and we will get back to you as quick as humanly possible


Subscribe to our mailing list

* indicates required

Opt out of occasional 3rd party offers


0